| Status | Study |
| Completed |
Study Name: Comparative Study Efficacy and Safety of of Activated Versus Non-Activated PRP Condition: Alopecia Areata Date: 2022-01-02 Interventions: Interventional |
| Active, not recruiting |
Study Name: Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata Condition: Alopecia Areata Date: 2016-02-11 Interventions: Drug: Apremilast Subjects will |
| Recruiting |
Study Name: A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata Condition: Alopecia Areata Date: 2016-02-11 Interventions: Drug: Tralokinumab All groups |
| Recruiting |
Study Name: Topical Garlic Concentrate for Alopecia Areata in Children Condition: Alopecia Areata Date: 2015-12-15 Interventions: Drug: garlic concentrate Topical application of GarlicRich gel on the scalp areas affected with alopecia |
| Terminated |
Study Name: A Study of Secukinumab for the Treatment of Alopecia Areata Condition: Alopecia Areata Date: 2015-11-04 Interventions: Drug: Secukinumab subcutaneous |
| Active, not recruiting |
Study Name: A Study With INCB018424 Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA) Condition: Alopecia Areata Date: 2015-09-16 Interventions: Drug: Placebo Cream Drug: INCB018424 Phosp |
| Completed |
Study Name: Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata Condition: Alopecia Areata Date: 2015-01-20 Interventions: Drug: Topical latanoprost 0.005% |
| Active, not recruiting |
Study Name: Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis Condition: Alopecia Areata Date: 2014-11-14 Interventions: Drug: Tofacitinib Other Name: XELJANZ |
| Active, not recruiting |
Study Name: An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata Condition: Alopecia Areata Date: 2013-12-17 Interventions: Drug: Abatacept After the screening period, subjects will |
| Completed |
Study Name: Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata Condition: Alopecia Areata Date: 2013-09-23 Interventions: Drug: Ruxolitinib A fixed dose of ruxolitinib (20mg) will be self-administered orally twice daily for 12 |